Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore various ways to find innovative business ideas that encourage you to think outside the box and create unique solutions.
17,339 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A bold Independence Day plan envisions millions of U.S. kids gaining a financial stake in the economy, blending phila...
In a volatile market, the dividend growth approach that emphasizes rising payouts over big yields is drawing attentio...
Amazon's AI hardware strategy could extend far beyond cloud services. This article explains how Trainium and Inferent...
Meta Platforms is dialing up AI infrastructure spending, guiding 2026 capex to $125-145 billion after a strong Q1. Th...
MassMutual CEO Roger Crandall frames the mounting debt burden as a daily drag on households and long-term growth. The...
Federal bank regulators issued joint guidance to remind lenders to assess credit risk when borrowers lack work author...
A high-stakes pivot: the team behind ethereum's institutional privacy push launches EthSystems, a for-profit venture ...
American manufacturers are racing to deploy fully automated, lights-out factories in North America as robotics and AI...
Jefferies positions Amazon as the leading Mag 7 stock headed into earnings, underscoring AWS momentum, Prime Day stre...
Meta and Microsoft posted strong results, yet insider selling patterns diverged sharply. Meta's executives have been ...
Two prominent analysts lifted price targets on Newell Brands, sparking a rally where the stock raced higher. This art...